pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 17·1 min read
save

General Catalyst outlines tech collaborations with Summa Health after hospital acquisition

Sep 17, 2026·read at Endpoints ↗Neutral

General Catalyst, a venture capital firm, is now describing how it plans to integrate technology with Summa Health following its purchase of the hospital network.

The firm says the focus will be on digital tools that improve patient flow, data sharing, and operational efficiency across Summa’s facilities.

By leveraging partnerships with tech providers, General Catalyst aims to test new care models that could be replicated in other health systems.

The initiative reflects the investor’s broader ambition to reshape hospital operations through technology, building on the earlier acquisition.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “General Catalyst details tech partnerships at Summa Health”

read at Endpoints ↗
86 words · retrieved Sep 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 17h agoAnthropic’s one-person biotech buy; Jake Van Naarden’s dealmaking strategy; and moreEndpoints
  • 1d agoSanofi may seek higher European drug prices, not withhold launches, under Trump dealEndpoints
  • 1d agoGilead CAR-T on partial clinical hold; Agios' PDUFA date pushed backEndpoints
  • 1d agoAstraZeneca says reorg could mean R&D cuts and trials shifted to emerging marketsEndpoints
  • 1d agoAnthropic's Nathan Frey on biopharma partners, M&A and pipelineEndpoints